What happens when first-line FIP treatment isn’t enough? Dr Sally Coggins shares 2025 insights on treating tough FIP cases—molnupiravir, paxlovid, rescue therapy, and shorter, safer treatment protocols.
FIP is treatable—but the real challenge? Treating it right. Dr. Sally Coggins returns to clarify what’s what in the wave of new treatment options for feline infectious peritonitis. From updated 2025 dosing protocols to practical strategies for real-world cases, this episode bridges cutting-edge evidence and everyday decision-making.
This episode brings together Dr. Sally Coggins (University of Sydney), Prof. Danielle Gunn-Moore, and Dr. Sam Taylor for a 2025 update on FIP diagnostics: what’s new, what’s practical, and how to balance certainty with urgency when a sick kitten is in front of you.
In this episode, made and shared by The Vet Vault, we explore how the stakes of getting it wrong have changed now that effective treatment is available. You’ll learn how to sharpen your diagnostic edge and avoid expensive detours by recognising FIP mimics that can lead even experienced vets astray. We cover the usual suspects, as well as the rare imposters, and help you decide when it’s safe to treat empirically—and when to hit pause.
In this episode from the Vet Vault FIP Masterclass Podcast Series, our two FIP experts break down the fast, non-invasive clues that build your clinical suspicion before jumping to invasive expensive diagnostics. You’ll learn to leverage “free” intel like signalment, weight, behavior, ocular changes – with a few pro tips thrown in for good measure – to sniff out FIP in general practice.
Join host Brett Davidson interviews Nick Bova, Managing Director of Bova, to explore the reality behind Quality Assurance in veterinary compounding.
With some compounding pharmacies claiming Quality Assured products/facilities, Brett and Nick dive into what “Quality” truly means, how it’s regulated, and why the standards are often misunderstood. Drawing on Nick’s experience from establishing Bova UK under strict GMP regulations—standards that Australian pharmacies are not required to follow—they discuss the lack of oversight in the Australian veterinary compounding industry.
The QA program Bova has implemented is a unique approach developed in consultation with regulatory bodies. This insightful conversation sheds light on the critical differences in global veterinary compounding practices and the real meaning of quality assurance.
In a VETchat episode, Professor Danielle Gunn-Moore discussed feline medicine, focusing on mycobacterium and feline infectious peritonitis (FIP). They addressed the current outbreak of FIP in Cyprus and the emergence of the FCoV-23 variant found in cats of all ages. Gunn-Moore emphasized the improved treatment for mycobacterium and the need for proactive measures against FCoV-23.
How long should antibiotics be prescribed in pets? Join Dr Fergus Allerton to explore the evidence behind course duration and tackle antimicrobial resistance.